News | Computed Tomography (CT) | June 17, 2019

International Working Group Releases New Multiple Myeloma Imaging Guidelines

Recommendations guide optimal use of new imaging techniques

International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

June 17, 2019 — An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for imaging techniques to help diagnose multiple myeloma and other plasma-cell disorders.

Just as newer drugs have significantly improved outcomes for patients with multiple myeloma in the past decade, newer imaging techniques are upgrading detection of the disease, leading to earlier treatment. But standards to help guide clinicians on the optimal use of advanced imaging have lagged behind until now.

Jens Hillengass, M.D., chief of myeloma at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., led the IMWG effort to compile new recommendations for imaging techniques that offer more sensitive and accurate diagnosis and monitoring for patients with multiple myeloma and other plasma-cell disorders. Multiple myeloma — the second most common type of blood cancer — occurs when white blood cells known as plasma cells multiply out of control.

“Use of newer imaging techniques is changing the whole landscape, from diagnosis to treatment to supportive care to survivorship, and all those things are coming into this direction of research in multiple myeloma right now,” said Hillengass.

Hillengass and a team of two experts developed the guidelines, which were then reviewed by the entire working group. Their findings have been newly published in the journal The Lancet Oncology.1

The guidelines are based in part on an examination of results of computed tomography (CT) and X-ray imaging from several countries. The team found that using only conventional X-ray misses 25 percent of instances where patients have bone destruction already and need treatment.

“There has to be destruction of 30-50 percent of the bone, sometimes up to 70 percent, before you see anything on X-ray,” said Hillengass, who is first author on the new guidelines. “More sophisticated imaging is necessary not only in the beginning to assess the disease but also to assess the response and to see what is left after our standard treatment. Myeloma is a disease that can cause focal and diffuse destruction of the bone, and to see that, you need sharp imaging.”

The major change in the new imaging guidelines is that whole-body low-dose CT replaces conventional skeletal survey as the standard imaging technique recommended for assessing bone destruction. The IMWG team recommends that this more sophisticated technique and others, including positron emission tomography-CT (PET-CT) and magnetic resonance imaging (MRI) be introduced generally into clinical practices.

These practices are already employed in the clinical care of myeloma patients at Roswell Park, and a team at the cancer center is conducting a clinical trial to explore what CT-guided biopsies of focal lesions may reveal about the spatial and temporal heterogeneity of this disease.

Hillengass hopes that broader application of these newer techniques will lead to more refined imaging, more accurate diagnoses, earlier treatments and more patients living longer due to lasting remissions.

“There’s a lot of research underway now exploring whether incorporating more specific traces or dyes into various imaging techniques will be beneficial, and also to figure out how we can assess minimal residual disease, or very low tumor burdens after treatment,” he noted. “Therefore, we need much higher sensitivity and also functional information that cutting-edge imagery can provide. There are important questions still to be asked as these technologies evolve.”

The International Myeloma Foundation formed the IMWG in 2001 to encourage dialogue and collaboration among the world’s leading myeloma experts. The group includes 243 members from 39 countries who collaboratively conduct research to improve outcomes of the disease and provide scientifically valid consensus opinions regarding its diagnosis and treatment.

The paper, “International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders, is available online.

For more information: www.sciencedirect.com

Reference

1. Hillengass J., Usmani S., Rajkumar S.V., et al. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. The Lancet Oncology, published online May 29, 2019. https://doi.org/10.1016/S1470-2045(19)30309-2

Related Content

The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source computed tomography (CT) scanner from Siemens Healthineers together with the new myExam Companion intelligent user interface concept
News | Computed Tomography (CT) | November 21, 2019
November 21, 2019 — The Food and Drug Administration (FDA) has cleared the new Somatom X.cite premium single-source
 Prostate cancer MRI
News | Clinical Trials | November 15, 2019
November 15, 2019 — Theragnostics, which is developing innovative radiopharm
The study finds it's possible to use commercial facial recognition software to identify people from brain MRI that includes imagery of the face
News | Magnetic Resonance Imaging (MRI) | November 15, 2019
November 15, 2019 — Though identifying data typically are removed from medical image files before they are shared for
62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

News | PET-CT | November 15, 2019
November 15, 2019 — According to an article published ahead-of-print in the...
An image on Brigham and Women's Hospital's 7T MRI system

An image on Brigham and Women's Hospital's 7T MRI system. Image courtesy of Brigham and Women's Hospital

News | Magnetic Resonance Imaging (MRI) | November 13, 2019
November 13, 2019 — Increased immune system activity along the surface of the brain, or meningeal inflammation, may b
Radiographer Apollo Exconde with his Lego concept open MRI for patient education.

Radiographer Apollo Exconde with his Lego concept open MRI for patient education.

News | Patient Engagement | November 11, 2019
November 11, 2019 — Radiographer Apollo Exconde...
Image by Dr. Manuel González Reyes from Pixabay

Image by Dr. Manuel González Reyes from Pixabay 

News | SPECT Imaging | November 08, 2019
November 8, 2019 — Using ground-breaking technology, researchers at the...
Unlike other technologies for imaging the placenta, pCASL MRI can distinguish maternal blood from fetal blood

Image courtesy of Pixabay

News | Clinical Trials | November 07, 2019
November 7, 2019 — A new imaging technique to track
Radiology: Cardiothoracic Imaging has published a special report on lung injury resulting from the use of electronic cigarettes (e-cigarettes), or “vaping.”

Image by Lindsay Fox from Pixabay

News | Computed Tomography (CT) | November 06, 2019
November 6, 2019 — Radiology: Cardiothoracic Imaging has published a special report on lung injury resulting